2-165572871-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001172173.2(CSRNP3):c.-23-22172T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.363 in 152,042 control chromosomes in the GnomAD database, including 10,183 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.36 ( 10183 hom., cov: 32)
Consequence
CSRNP3
NM_001172173.2 intron
NM_001172173.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.184
Publications
1 publications found
Genes affected
CSRNP3 (HGNC:30729): (cysteine and serine rich nuclear protein 3) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Predicted to be involved in positive regulation of apoptotic process and positive regulation of transcription by RNA polymerase II. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CSRNP3 | NM_001172173.2 | c.-23-22172T>G | intron_variant | Intron 3 of 6 | ENST00000651982.1 | NP_001165644.1 | ||
| CSRNP3 | NM_024969.3 | c.-24+284T>G | intron_variant | Intron 1 of 4 | NP_079245.2 | |||
| CSRNP3 | XM_024453155.2 | c.-23-22172T>G | intron_variant | Intron 4 of 7 | XP_024308923.1 | |||
| CSRNP3 | XM_047445908.1 | c.-23-22172T>G | intron_variant | Intron 3 of 6 | XP_047301864.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.363 AC: 55196AN: 151924Hom.: 10183 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
55196
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.363 AC: 55219AN: 152042Hom.: 10183 Cov.: 32 AF XY: 0.367 AC XY: 27269AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
55219
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
27269
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
13152
AN:
41486
American (AMR)
AF:
AC:
4191
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1539
AN:
3468
East Asian (EAS)
AF:
AC:
2351
AN:
5164
South Asian (SAS)
AF:
AC:
2323
AN:
4824
European-Finnish (FIN)
AF:
AC:
4302
AN:
10554
Middle Eastern (MID)
AF:
AC:
109
AN:
290
European-Non Finnish (NFE)
AF:
AC:
26289
AN:
67960
Other (OTH)
AF:
AC:
720
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1778
3556
5335
7113
8891
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1467
AN:
3448
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.